SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-20-211999
Filing Date
2020-08-06
Accepted
2020-08-06 16:47:53
Documents
3
Group Members
ANNE-MARI PASTERCLAUDIO NESSIOMEGA FUND VI GP MANAGER, LTD.OMEGA FUND VI GP, L.P.OTELLO STAMPACCHIA

Document Format Files

Seq Description Document Type Size
1 SC 13G d23684dsc13g.htm SC 13G 133612
2 EX-99.1 d23684dex991.htm EX-99.1 7447
3 EX-99.2 d23684dex992.htm EX-99.2 11561
  Complete submission text file 0001193125-20-211999.txt   154465
Mailing Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
Business Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199 617-502-6538
Omega Fund IV, L.P. (Filed by) CIK: 0001528382 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Subject) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88896 | Film No.: 201082418
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences